Format
Sort by
Items per page

Send to

Choose Destination

Best matches for rotavirus AND sensitivity analysis AND vaccines:

Search results

Items: 1 to 20 of 65

1.

Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.

Hungerford D, Smith K, Tucker A, Iturriza-Gómara M, Vivancos R, McLeonard C, A Cunliffe N, French N.

BMC Infect Dis. 2017 Aug 15;17(1):569. doi: 10.1186/s12879-017-2613-4.

2.

Hospitalizations for Respiratory Syncytial Virus and Vaccine-Preventable Infections in the First 2 Years After Pediatric Liver Transplant.

Feldman AG, Sundaram SS, Beaty BL, Kempe A.

J Pediatr. 2017 Mar;182:232-238.e1. doi: 10.1016/j.jpeds.2016.12.021. Epub 2017 Jan 11.

PMID:
28088400
3.

Directed chromosomal integration and expression of porcine rotavirus outer capsid protein VP4 in Lactobacillus casei ATCC393.

Yin JY, Guo CQ, Wang Z, Yu ML, Gao S, Bukhari SM, Tang LJ, Xu YG, Li YJ.

Appl Microbiol Biotechnol. 2016 Nov;100(22):9593-9604. Epub 2016 Aug 24.

PMID:
27557715
4.

Investigation of Rotavirus with Various Methods in Children with Acute Gastroenteritis and Determination of Its Molecular Epidemiology in Kayseri Province, Turkey.

Artiran S, Atalay A, Gökahmetoglu S, Ozturk MA, Balci N, Cakir N, Kilic H, Durmaz R.

J Clin Lab Anal. 2017 Mar;31(2). doi: 10.1002/jcla.22030. Epub 2016 Jul 25.

PMID:
27451970
5.

Establishment of a nanoparticle-assisted RT-PCR assay to distinguish field strains and attenuated strains of porcine epidemic diarrhea virus.

Zhu Y, Wang GH, Cui YD, Cui SJ.

Arch Virol. 2016 Sep;161(9):2543-7. doi: 10.1007/s00705-016-2918-4. Epub 2016 Jun 10.

PMID:
27287433
6.

Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies.

Tate JE, Patel MM, Cortese MM, Payne DC, Lopman BA, Yen C, Parashar UD.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S106-14. doi: 10.1093/cid/civ1014.

PMID:
27059343
7.

[A cost-effectiveness analysis on universal infant rotavirus vaccination strategy in China].

Sun SL, Gao YQ, Yin J, Zhuang GH.

Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Feb;37(2):238-42. doi: 10.3760/cma.j.issn.0254-6450.2016.02.018. Chinese.

PMID:
26917523
8.

Healthcare Costs of Rotavirus and Other Types of Gastroenteritis in Children in Norway.

Shin M, Salamanca BV, Kristiansen IS, Flem E.

Pediatr Infect Dis J. 2016 Apr;35(4):e97-e101. doi: 10.1097/INF.0000000000001026.

PMID:
26658381
9.

Systematic review of economic evaluations of vaccination programs in mainland China: Are they sufficient to inform decision making?

Pan XF, Griffiths UK, Pennington M, Yu H, Jit M.

Vaccine. 2015 Nov 17;33(46):6164-72. doi: 10.1016/j.vaccine.2015.09.081. Epub 2015 Oct 2. Review.

PMID:
26435189
10.

Cost-Effectiveness of Rotavirus Vaccination for Under-Five Children in Iran.

Shakerian S, Moradi Lakeh M, Esteghamati A, Zahraei M, Yaghoubi M.

Iran J Pediatr. 2015 Aug;25(4):e2766. doi: 10.5812/ijp.2766. Epub 2015 Aug 24.

11.

Cost effectiveness evaluation of a rotavirus vaccination program in Argentina.

Martí SG, Alcaraz A, Valanzasca P, McMullen M, Standaert B, Garay U, Lepetic A, Gomez J.

Vaccine. 2015 Oct 13;33(42):5684-90. doi: 10.1016/j.vaccine.2015.08.026. Epub 2015 Aug 21.

PMID:
26303875
12.

Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008-2014.

Haber P, Parashar UD, Haber M, DeStefano F.

Vaccine. 2015 Sep 11;33(38):4873-7. doi: 10.1016/j.vaccine.2015.07.054. Epub 2015 Aug 11.

PMID:
26276687
13.

Methodological challenges in measuring vaccine effectiveness using population cohorts in low resource settings.

King C, Beard J, Crampin AC, Costello A, Mwansambo C, Cunliffe NA, Heyderman RS, French N, Bar-Zeev N; VacSurv Consortium.

Vaccine. 2015 Sep 11;33(38):4748-55. doi: 10.1016/j.vaccine.2015.07.062. Epub 2015 Jul 30. Review.

14.

Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran.

Javanbakht M, Moradi-Lakeh M, Yaghoubi M, Esteghamati A, Mansour Ghanaie R, Mahmoudi S, Shamshiri AR, Zahraei SM, Baxter L, Shakerian S, Chaudhri I, Fleming JA, Munier A, Baradaran HR.

Vaccine. 2015 May 7;33 Suppl 1:A192-200. doi: 10.1016/j.vaccine.2014.12.035.

PMID:
25919160
15.

Cost-effectiveness analysis of rotavirus vaccination among Libyan children using a simple economic model.

Alkoshi S, Maimaiti N, Dahlui M.

Libyan J Med. 2014 Dec 9;9:26236. doi: 10.3402/ljm.v9.26236. eCollection 2014.

16.

Novel algorithms for improved pattern recognition using the US FDA Adverse Event Network Analyzer.

Botsis T, Scott J, Goud R, Toman P, Sutherland A, Ball R.

Stud Health Technol Inform. 2014;205:1178-82.

PMID:
25160375
17.

Cost-effectiveness of childhood rotavirus vaccination in Germany.

Aidelsburger P, Grabein K, Böhm K, Dietl M, Wasem J, Koch J, Ultsch B, Weidemann F, Wichmann O.

Vaccine. 2014 Apr 7;32(17):1964-74. doi: 10.1016/j.vaccine.2014.01.061. Epub 2014 Feb 20.

PMID:
24561052
18.

Budget constraint and vaccine dosing: a mathematical modelling exercise.

Standaert BA, Curran D, Postma MJ.

Cost Eff Resour Alloc. 2014 Jan 22;12(1):3. doi: 10.1186/1478-7547-12-3.

19.

Real-time RT-PCR assays to differentiate wild-type group A rotavirus strains from Rotarix(®) and RotaTeq(®) vaccine strains in stool samples.

Gautam R, Esona MD, Mijatovic-Rustempasic S, Ian Tam K, Gentsch JR, Bowen MD.

Hum Vaccin Immunother. 2014;10(3):767-77. Epub 2013 Dec 16.

20.

Estimating the costs of implementing the rotavirus vaccine in the national immunisation programme: the case of Malawi.

Madsen LB, Ustrup M, Hansen KS, Nyasulu PS, Bygbjerg IC, Konradsen F.

Trop Med Int Health. 2014 Feb;19(2):177-85. doi: 10.1111/tmi.12233. Epub 2013 Dec 9.

Supplemental Content

Loading ...
Support Center